Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: Effect of DL-α-lipoic acid

European Journal of Pharmacology

Volumn 398, Issue 1, 2000, Pages 139-146

  Obrosova, Irina G ^a   Fathallah, Lamia ^a   Greene, Douglas A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Antioxidant; Diabetic retinopathy; Glutathione; Lipid peroxidation; Superoxide dismutase

Indexed keywords

THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DRUG EFFECT; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; GLUTATHIONE; GLUTATHIONE DISULFIDE; LIPID PEROXIDATION; MALE; RATS; RATS, WISTAR; RETINA; SUPEROXIDE DISMUTASE; THIOCTIC ACID;

EID: 0034625764     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00286-7     Document Type: Article

References (75)

1. Aebi H. Catalase. Bergmeyer H. Methods of Enzymatic Analysis. 1974;673-684 Academic Press, New York.
2. Agardh C.D., Agardh E., Qian Y., Hultberg B. Glutathione levels are reduced in diabetic rat retina but are not influenced by ischemia followed by recirculation. Metabolism. 47:1998;269-272.
3. Ansari N.H., Zhang W., Fulep E. Prevention of pericyte loss by trolox in diabetic rat retina. J. Toxicol. Environ. Health. 54:1998;467-475.
4. Arai K., Maguchi S., Fujii S., Ishibashi H., Oikawa K., Taniguchi N. Glycation and inactivation of human Cu,Zn-superoxide dismutase. Identification of the in vitro glycated sites. J. Biol. Chem. 262:1987;16969-16972.
5. Bashan N., Burdett E., Gum A. Effect of thioctic acid on glucose transport. Gries F.A., Wessel E. The Role of Anti-oxidants in Diabetes Mellitus - Oxygen Radicals and Antioxidants in Diabetes. 1993;221-226 pmi Verlag-Gruppe, Frankfurt am Main.
6. Block F., Schwartz M. Effects of antioxidants on ischemic retinal dysfunction. Exp. Eye Res. 64:1997;559-564.
7. Bose R., Sutherland G.R., Pinsky C. Biological and methodological implications of prostaglandin involvement in mouse brain lipid peroxidation measurements. Neurochem. Res. 14:1989;217-220.
8. Cameron N.E., Cotter M.A., Horrobin D.H., Tritschler H.J. Effect of α-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids. Diabetologia. 41:1998;390-399.
9. Cameron N.E., Cotter M.A., Jack A.M., Basso M.D., Hohman T.C. Protein kinase C effects on nerve function, perfusion, Na+-K+-ATPase activity and glutathione content in diabetic rats. Diabetologia. 42:1999;1120-1131.
10. Carroll P.B., Thornton B.M., Greene D.A. Glutathione redox state is not the link between polyol pathway activity and myo-inositol-related Na+-K+-ATPase defect in experimental diabetic neuropathy. Diabetes. 35:1986;1282-1285.
11. Chemtob S., Hardy P., Abran D., Li D.Y., Peri K., Cuzzani O., Varma D.R. Peroxide-cyclooxygenase interactions in postphyxial changes in retinal and choroidal hemodynamics. J. Appl. Physiol. 78:1995;2039-2046.
12. Chen J., Schenker S., Frosto T.A., Henderson G.I. Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE). Role of HNE adduct formation with the enzyme subunits. Biochim. Biophys. Acta. 1380:1998;336-344.
13. Ellis E.A., Grant M.B., Murray F.T., Wachowski M.B., Guberski D.L., Kubilis P.S., Lutty G.A. Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radical Biol. Med. 24:1998;111-120.
14. Erdelmeier I., Gerard-Monnier D., Yadan J.C., Chaudiere J. Reactions of N-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Mechanistic aspects of the colorimetric assay of lipid peroxidation. Chem. Res. Toxicol. 11:1998;1184-1194.
15. Ernster L. DT diaphorase. Methods Enzymol. 10:1967;309-317.
16. Esterbauer H. Cytotoxicity and genotoxicity of lipid-oxidation products. Am. J. Clin. Nutr. 57(Suppl. 5):1993;779S-785S. discussion 785S-786S.
17. Esterbauer H., Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malondialdehyde and 4-hydroxynonenal. Methods Enzymol. 186:1990;407-421.
18. Fang C., Jiang Z., Tomlinson D.R. Expression of constitutive cyclo-oxygenase (COX-1) in rats with streptozotocin-induced diabetes; effects of treatment woth evening primrose oil or an aldose reductase inhibitor on COX-1 mRNA levels. Prostaglandins, Leukotrienes Essent. Fatty Acids. 56:1997;157-163.
19. Fisher G.R., Gutierrez P.L. Free radical formation and DNA strand breakage during metabolism of diaziquone by NAD(P)H quinone-acceptor oxidoreductase (DT-diaphorase) and NADPH cytochrome c reductase. Free Radical Biol. Med. 11:1991;597-607.
20. Floreani M., Petrone M., Debetto P., Palatini P. A comparison between different methods for the determination of reduced and oxidized glutathione in mammalian tissues. Free Radical Res. 26:1997;449-455.
21. Frank R.N., Amin R., Kennedy A., Hohman T.C. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia. Arch. Ophthalmol. 115:1997;1036-1047.
22. Garrett N.E., Malcangio M., Dewhurst M., Tomlinson D.R. α-Lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support. Neurosci. Lett. 222:1997;191-194.
23. Gutteridge J.M.C. Thiobarbituric acid-reactivity following iron-dependent free-radical damage to amino acids and carbohydrates. FEBS Lett. 128:1981;343-346.
24. Hammes H.P., Bartmann A., Engel L., Wulfroth P. Antioxidant treatment of exprimental diabetic retinopathy in rats with nicanartine. Diabetologia. 40:1997;629-634.
25. Hardy P., Abran D., Li D.Y., Fernandez H., Varma D.R., Chemtob C. Free radicals in retinal and choroidal blood flow autoregulation in the piglet: interaction with prostaglandins. Invest. Ophthalmol. Visual Sci. 35:1994;580-591.
26. Hartley D.P., Kroll D.J., Petersen D.R. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts. Chem. Res. Toxicol. 10:1997;895-905.
27. Hissin P.J., Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74:1976;214-226.
28. Kador P.F., Akagi Y., Takahashi Y., Ikebe H., Wyman M., Kinoshita J.H. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. Arch. Ophthalmol. 108:1990;1301-1309.
29. Kern T.S., Kowluru R.A., Engerman R.L. Abnormalities of retinal metabolism in diabetes or galactosemia: ATPases and glutathione. Invest. Ophthalmol. Visual Sci. 35:1995;2962-2967.
30. Kohner E.M., Aldington S.J., Stratton I.M., Manley S.E., Holman R.R., Matthews D.R., Turner R.C. United Kingdom Prospective Diabetes Study: 30. Diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch. Ophthalmol. 116:1998;297-303.
31. Kowluru R.A., Kern T.S., Engerman R.L., Armstrong D. Abnormalities of retinal metabolism in diabetes or experimental galactosemia: III. Effects of antioxidants. Diabetes. 45:1996;1233-1237.
32. Kowluru R.A., Kern T.S., Engerman R.L. Abnormalities of retinal metabolism in diabetes or experimental galactosemia: IY. Antioxidant defense system. Free Radical Biol. Med. 22:1997;587-592.
33. Kruman I., Bruce-Keller A.J., Bredesen D., Waeg G., Mattson M.P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17:1997;5089-5100.
34. Lee A.Y.W., Chung S.S.M. Contribution of polyol pathway to oxidative stress in diabetic cataract. FASEB J. 13:1999;23-30.
35. Lefevre G., Beljean-Leymarie M., Beyerle F., Bonnefont-Rousselot D., Cristol J.P., Therond P., Torreilles J. Evaluation de la peroxydation lipidique par le dosage des substances reagissant avec l'acide thiobarbiturique. Ann. Biol. Clin. 56:1998;305-319.
36. Lightman S., Rechthand E., Terubayashi H., Palestine A., Rapoport S., Kador P. Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors. Diabetes. 36:1987;1271-1275.
37. Lou M.F., Dickerson J.E. Jr., Garadi R., York B.M. Jr. Glutathione depletion in the lens of galactosemic and diabetic rats. Exp. Eye Res. 46:1988;517-530.
38. Low P.A., Yao J.K., Kishi Y., Tritschler H.J., Schmelzer J.D., Zollman P.J., Nickander K.K. Peripheral nerve energy metabolism in experimental diabetic neuropathy. Neurosci. Res. Comm. 21:1997;49-56.
39. Lowry O.H., Passonneau J.V. A Flexible System of Enzymatic Analysis. 1972;Academic Press, Orlando.
40. Maitra I., Serbinova E., Trischler H., Packer L. Alpha-lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborn rats. Free Radical Biol. Med. 18:1995;823-829.
41. Mattson M.P. Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci. 21:1998;53-57.
42. 4 intoxication, and vitamin E deficiency. Biochem. Med. 23:1980;302-311.
43. Misselwitz F., Norden C., Heine H. Individually controlled aspirin in the long-term treatment of patients with chronic arterial diseases. Angiology. 40:1989;464-471.
44. Mochizuki O. Studies on a platelet aggregation inhibitor isolated from the human placenta. Nippon Sanka Fujinka Gakkai Zasshi - Acta Obstet. Gynaecol. Jpn. 39:1987;1729-1736.
45. Morisaki N., Lindsey J.A., Stitts J.M., Zhang H., Cornwell D.G. Fatty acid metabolism and cell proliferation: Y. Evaluation of pathways for the generation of lipid peroxides. Lipids. 19:1984;381-394.
46. Nagamatsu M., Nickander K.K., Schmelzer J.D., Ray A., Wittrock D.A., Tritschler H., Low P.A. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care. 18:1995;1160-1167.
47. Natarajan V., Scribner W.M., Vepa S. Phosphatase inhibitors potentiate 4-hydroxynonenal-induced phospholipase D activation in vascular endothelial cells. Am. J. Respir. Cell Mol. Biol. 17:1997;251-259.
48. Naveh-Floman N., Weissman C., Belkin M. Arachidonic acid metabolism by retinas of rats with streptozotocin-induced diabetes. Curr. Eye Res. 3:1984;1135-1139.
49. Neuenschwander H., Takahashi Y., Kador P.F. Dose-dependent reduction of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by the aldose reductase inhibitor M79175. J. Ocul. Pharmacol. Ther. 13:1997;517-528.
50. Nishida T., Nakagawa S., Manabe R. Superoxide dismutase activity in diabetic rat retina. Jpn. J. Ophthalmol. 28:1984;377-382.
51. Nistico G., Ciriolo M.R., Fiskin K., Iannone M., De Martino A., Rotilio G. NGF restores decrease in catalase activity and increases superoxide dismutase and glutathione peroxidase activity in the brain of aged rats. Free Radical Biol. Med. 12:1992;177-181.
52. Nuhrich A., Varache-Beranger M., Carpy A., Montagut M., Devaux G. Inhibitory effect of aryl thienyl-ketones and-thioketones on arachidonic acid-induced malondialdehyde formation in human platelets: biological data and molecular modelling. J. Enzyme Inhib. 5:1992;281-291.
53. Obrosova I.G., Stevens M.J. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens. Invest. Ophthalmol. Visual Sci. 40:1999;680-688.
54. Obrosova I., Cao X., Greene D.A., Stevens M.J. Diabetes-induced changes in lens antioxidant status, glucose utilization and energy metabolism: effect of DL-α-lipoic acid. Diabetologia. 41:1998;1442-1450.
55. Obrosova I.G., Lang H.J., Greene D.A. Antioxidative defense in diabetic peripheral nerve: role for aldose reductase and sorbitol dehydrogenase. Diabetologia. 41(Suppl. 1):1998;A270.
56. Obrosova I.G., Fathallah L., Lang H.J. Interaction between osmotic and oxidative stress in diabetic precataractous lens: studies with a sorbitol dehydrogenase inhibitor. Biochem. Pharmacol. 58:1999;1945-1954.
57. Packer L., Witt E.H., Trischler H.J. α-Lipoic acid as a biological antioxidant. Free Radical Biol. Med. 19:1995;227-250.
58. Paget C., Lecomte M., Ruggiero D., Wiernsperger N., Lagarde M. Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products. Free Radical Biol. Med. 25:1998;121-129.
59. Reddy V.N., Giblin F.J. Metabolism and function of glutathione in the lens. Ciba Found. Symp. 106:1984;65-87.
60. Rickman D.W., Brecha N.C. Expression of the proto-oncogene, trk, receptors in the developing rat retina. Visual Neurosci. 12:1995;215-222.
61. Romeo G., Podesta F., Kern T.S., Lorenzi M. Activated nuclear factor-κB (NF-κB) in pericytes is associated with early lesions of human diabetic retinopathy. Diabetes. 48(Suppl. 1):1999;A154.
62. Romero F.J., Monsalve E., Hermenegildo C., Puertas F.J., Higueras V., Nies E., Segura-Aguilar J., Roma J. Oxygen toxicity in the nervous tissue: comparison of the antioxidant defense of rat brain and sciatic nerve. Neurochem. Res. 16:1991;157-161.
63. Santos F.X., Escudero M., Perez L., Lozano T., Obispo J.M., Hamann C., Rodriguez C. Comparison of the effects of nerve growth factor and superoxide dismutase on vascular extravasation in experimental burns. Burns. 21:1995;445-448.
64. Sato S., Murata M., Ohta N., Tsai J.Y., Kador P.F. Galactose induces apoptosis of dog retinal capillary pericytes, but not of endothelial cells. Invest. Ophthalmol. Visual Sci. 40:1999;S370.
65. Simonelli F., Cotticelli L., Pensa M., Teramo P., Acampora A., Rinaldi E. Lipid peroxidation and cataract formation in experimental diabetes. Boll. Soc. Ital. Biol. Sper. 65:1989;759-765.
66. Takata I., Kawamura N., Myint T., Miyazawa N., Suzuki K., Maruyama N., Mino M., Taniguchi N. Glycated Cu,Zn-superoxide dismutase in rat lenses: evidence for the presence of fragmentation in vivo. Biochem. Biophys. Res. Commun. 219:1996;243-248.
67. Tampo Y., Yonada M. Enzymatic and molecular aspects of the antioxidant effect of menadione in hepatic microsomes. Arch. Biochem. Biophys. 334:1996;163-174.
68. Tanaka A., Motoyama Y., Takasugi H. Studies of anti-platelet agents: IY. A series of 2-substituted 4,5-bis(4-methoxyphenyl)pyrimidines as novel anti-platelet agents. Chem. Pharm. Bull. 42:1994;1828-1834.
69. Tanaka A., Sakai H., Motoyama Y., Ishikawa T., Takasugi H. Antiplatelet agents based on cyclooxygenase inhibition without ulcerogenesis. Evaluation and synthesis of 4,5-bis(4-methoxyphenyl)-2-substituted-thiazoles. J. Med. Chem. 37:1994;1189-1199.
70. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329:1993;977-986.
71. Tokyay R., Kaya E., Gur E.S., Tuncel P., Ozbek R., Ozturk E. Prostaglandin synthetase inhibition reduces peritonitis-induced early liver oxidant stress. Surg. Today. 29:1999;42-46.
72. Uchida K., Stadtman E.R. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. A possible involvement of intra- and intermolecular cross-linking reactions. J. Biol. Chem. 268:1993;6388-6393.
73. Van Dam P.S., Van Asbeck B.S., Bravenboer B., Van Oirschot J.F., Marx J.J., Gispen W.H. Nerve conduction and antioxidant levels in experimentally diabetic rats: effects of streptozotocin dose and diabetes duration. Metabolism. 48:1999;442-447.
74. Vinores S.A., McGehee R., Lee A., Gadegbeku C., Campochiaro P.A. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats. J. Histochem. Cytochem. 38:1990;1341-1352.
75. Watson A.J. Chemopreventive effects of NSAIDs against colorectal cancer: regulation of apoptosis and mitosis by COX-1 and COX-2. Histol. Histopathol. 13:1998;591-597.